KEGG   Homo sapiens (human): 958
Entry
958               CDS       T01001                                 
Symbol
CD40, Bp50, CDW40, TNFRSF5, p50
Name
(RefSeq) CD40 molecule
  KO
K03160  tumor necrosis factor receptor superfamily member 5
Organism
hsa  Homo sapiens (human)
Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04064  NF-kappa B signaling pathway
hsa04514  Cell adhesion molecules
hsa04620  Toll-like receptor signaling pathway
hsa04672  Intestinal immune network for IgA production
hsa05144  Malaria
hsa05145  Toxoplasmosis
hsa05166  Human T-cell leukemia virus 1 infection
hsa05169  Epstein-Barr virus infection
hsa05202  Transcriptional misregulation in cancer
hsa05310  Asthma
hsa05320  Autoimmune thyroid disease
hsa05322  Systemic lupus erythematosus
hsa05330  Allograft rejection
hsa05340  Primary immunodeficiency
hsa05416  Viral myocarditis
hsa05417  Lipid and atherosclerosis
Network
nt06160  Human T-cell leukemia virus 1 (HTLV-1)
nt06223  TNF signaling (cancer)
nt06240  Transcription (cancer)
nt06516  TNF signaling
  Element
N00123  Amplified REL to transcription
N00505  CD40-NFKB signaling pathway
Disease
H00086  Immunodeficiency with hyper-IgM
Drug target
Abiprubart: D13033
Bleselumab: D11357
Dacetuzumab: D08896
Iscalimab: D11610
Lucatumumab: D08942
Ravagalimab: D11597
Selicrelumab: D11491
Sotigalimab: D12178
Teneliximab: D06071
Brite
KEGG Orthology (KO) [BR:hsa00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04064 NF-kappa B signaling pathway
    958 (CD40)
  09133 Signaling molecules and interaction
   04060 Cytokine-cytokine receptor interaction
    958 (CD40)
   04514 Cell adhesion molecules
    958 (CD40)
 09150 Organismal Systems
  09151 Immune system
   04620 Toll-like receptor signaling pathway
    958 (CD40)
   04672 Intestinal immune network for IgA production
    958 (CD40)
 09160 Human Diseases
  09161 Cancer: overview
   05202 Transcriptional misregulation in cancer
    958 (CD40)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    958 (CD40)
   05169 Epstein-Barr virus infection
    958 (CD40)
  09174 Infectious disease: parasitic
   05144 Malaria
    958 (CD40)
   05145 Toxoplasmosis
    958 (CD40)
  09163 Immune disease
   05310 Asthma
    958 (CD40)
   05322 Systemic lupus erythematosus
    958 (CD40)
   05320 Autoimmune thyroid disease
    958 (CD40)
   05330 Allograft rejection
    958 (CD40)
   05340 Primary immunodeficiency
    958 (CD40)
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    958 (CD40)
   05416 Viral myocarditis
    958 (CD40)
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04050 Cytokine receptors [BR:hsa04050]
    958 (CD40)
   04090 CD molecules [BR:hsa04090]
    958 (CD40)
Cytokine receptors [BR:hsa04050]
 Tumor necrosis factor receptors
  TNF receptor superfamily
   958 (CD40)
CD molecules [BR:hsa04090]
 Proteins
  958 (CD40)
SSDB
Motif
Pfam: TNFR_c6 RANK_CRD_2 DUF6479 Syndecan
Other DBs
NCBI-GeneID: 958
NCBI-ProteinID: NP_001241
OMIM: 109535
HGNC: 11919
Ensembl: ENSG00000101017
UniProt: P25942 A0A0S2Z3C7 Q6P2H9
Structure
LinkDB
Position
20:46118314..46129858
AA seq 277 aa
MVRLPLQCVLWGCLLTAVHPEPPTACREKQYLINSQCCSLCQPGQKLVSDCTEFTETECL
PCGESEFLDTWNRETHCHQHKYCDPNLGLRVQQKGTSETDTICTCEEGWHCTSEACESCV
LHRSCSPGFGVKQIATGVSDTICEPCPVGFFSNVSSAFEKCHPWTSCETKDLVVQQAGTN
KTDVVCGPQDRLRALVVIPIIFGILFAILLVLVFIKKVAKKPTNKAPHPKQEPQEINFPD
DLPGSNTAAPVQETLHGCQPVTQEDGKESRISVQERQ
NT seq 834 nt   +upstreamnt  +downstreamnt
atggttcgtctgcctctgcagtgcgtcctctggggctgcttgctgaccgctgtccatcca
gaaccacccactgcatgcagagaaaaacagtacctaataaacagtcagtgctgttctttg
tgccagccaggacagaaactggtgagtgactgcacagagttcactgaaacggaatgcctt
ccttgcggtgaaagcgaattcctagacacctggaacagagagacacactgccaccagcac
aaatactgcgaccccaacctagggcttcgggtccagcagaagggcacctcagaaacagac
accatctgcacctgtgaagaaggctggcactgtacgagtgaggcctgtgagagctgtgtc
ctgcaccgctcatgctcgcccggctttggggtcaagcagattgctacaggggtttctgat
accatctgcgagccctgcccagtcggcttcttctccaatgtgtcatctgctttcgaaaaa
tgtcacccttggacaagctgtgagaccaaagacctggttgtgcaacaggcaggcacaaac
aagactgatgttgtctgtggtccccaggatcggctgagagccctggtggtgatccccatc
atcttcgggatcctgtttgccatcctcttggtgctggtctttatcaaaaaggtggccaag
aagccaaccaataaggccccccaccccaagcaggaaccccaggagatcaattttcccgac
gatcttcctggctccaacactgctgctccagtgcaggagactttacatggatgccaaccg
gtcacccaggaggatggcaaagagagtcgcatctcagtgcaggagagacagtga

KEGG   DISEASE: Immunodeficiency with hyper-IgM
Entry
H00086                      Disease                                
Name
Immunodeficiency with hyper-IgM
  Supergrp
Combined immunodeficiency [DS:H00093]
Disorders of adaptive immunity [DS:H02526]
Primary immunodeficiency disease [DS:H01725]
Description
There are three major categories of antibody deficiencies: (a) defects in early B cell development, (b) hyper-IgM syndromes (also called class switch recombination defects), and (c) common variable immunodeficiency (CVID). Category (b), hyper-IgM syndrome (HIM), represents a group of distinct entities characterized by defective normal or elevated IgM in the presence of diminished IgG and IgA levels. Seventy per cent of the cases are X-linked in inheritance, and others are autosomal recessive. In the autosomal recessive hyper IgM syndromes, the problem lies in the nucleotide-editing enzymes AICD or UNG. These enzymes are only present in the germinal center B cells, and defects in either disrupt B-cell development and antibody production. Patients with these syndromes typically have recurrent bacterial infections and often have lymphoid hyperplasia.
Category
Immune system disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
 04 Diseases of the immune system
  Primary immunodeficiencies
   4A01  Primary immunodeficiencies due to disorders of adaptive immunity
    H00086  Immunodeficiency with hyper-IgM
Pathway-based classification of diseases [BR:br08402]
 Replication and repair
  nt06504  Base excision repair
   H00086  Immunodeficiency with hyper-IgM
 Signal transduction
  nt06516  TNF signaling
   H00086  Immunodeficiency with hyper-IgM
Pathway
hsa04672  Intestinal immune network for IgA production
hsa03410 Base excision repair   
hsa04064  NF-kappa B signaling pathway
Network
nt06504 Base excision repair
nt06516 TNF signaling
Gene
(HIGM1) CD40LG [HSA:959] [KO:K03161]
(HIGM2) AICDA [HSA:57379] [KO:K10989]
(HIGM3) CD40 [HSA:958] [KO:K03160]
(HIGM5) UNG [HSA:7374] [KO:K03648]
Other DBs
ICD-11: 4A01.05
MeSH: D053306 D053307
OMIM: 308230 605258 606843 608106
Reference
  Authors
Kumar A, Teuber SS, Gershwin ME.
  Title
Current perspectives on primary immunodeficiency diseases.
  Journal
Clin Dev Immunol 13:223-59 (2006)
DOI:10.1080/17402520600800705
Reference
  Authors
Morra M, Geigenmuller U, Curran J, Rainville IR, Brennan T, Curtis J, Reichert V, Hovhannisyan H, Majzoub J, Miller DT.
  Title
Genetic diagnosis of primary immune deficiencies.
  Journal
Immunol Allergy Clin North Am 28:387-412, x (2008)
DOI:10.1016/j.iac.2008.01.004
Reference
PMID:26903548 (CD40LG)
  Authors
Hubbard N, Hagin D, Sommer K, Song Y, Khan I, Clough C, Ochs HD, Rawlings DJ, Scharenberg AM, Torgerson TR
  Title
Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome.
  Journal
Blood 127:2513-22 (2016)
DOI:10.1182/blood-2015-11-683235
Reference
PMID:11007475 (AICDA)
  Authors
Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A, Durandy A
  Title
Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).
  Journal
Cell 102:565-75 (2000)
DOI:10.1016/s0092-8674(00)00079-9
Reference
PMID:9842907 (CD40)
  Authors
Revy P, Geissmann F, Debre M, Fischer A, Durandy A
  Title
Normal CD40-mediated activation of monocytes and dendritic cells from patients with hyper-IgM syndrome due to a CD40 pathway defect in B cells.
  Journal
Reference
PMID:12958596 (UNG)
  Authors
Imai K, Slupphaug G, Lee WI, Revy P, Nonoyama S, Catalan N, Yel L, Forveille M, Kavli B, Krokan HE, Ochs HD, Fischer A, Durandy A
  Title
Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination.
  Journal
Nat Immunol 4:1023-8 (2003)
DOI:10.1038/ni974
LinkDB

» Japanese version

KEGG   DISEASE: Combined immunodeficiency
Entry
H00093                      Disease                                
Name
Combined immunodeficiency
  Subgroup
Bare lymphocyte syndrome type 1 [DS:H00984]
Bare lymphocyte syndrome type 2 [DS:H00985]
Immunodeficiency with hyper-IgM [DS:H00086]
Combined cellular and humoral deficiencies and multiple granulomas (CCHDG)
  Supergrp
Disorders of adaptive immunity [DS:H02526]
Primary immunodeficiency disease [DS:H01725]
Description
The term combined immunodeficiency (CID) is used to distinguish patients with low, but not absent, T-cell function from those with severe CID (SCID) characterized by profound deficiencies of T- and B-cell (and sometimes NK- cell) function. Hyper-IgM syndrome (HIM) [DS:H00086] represents a group of distinct entities characterized by defective normal or elevated IgM in the presence of diminished IgG and IgA levels. The genetic anomaly in X-linked hyper-IgM syndrome has been mapped to Xq26, and resides in mutations of the CD40 ligand gene. ZAP-70 deficiency is inherited in an autosomal recessive manner. Recurrent and opportunistic infections occur within the first year of life. The mutations in genes responsible for CRAC channel function, ORAI1 and STIM1, cause the defect in Ca2+ influx.
Category
Primary immunodeficiency
Brite
Human diseases in ICD-11 classification [BR:br08403]
 04 Diseases of the immune system
  Primary immunodeficiencies
   4A01  Primary immunodeficiencies due to disorders of adaptive immunity
    H00093  Combined immunodeficiency
Pathway-based classification of diseases [BR:br08402]
 Replication and repair
  nt06509  DNA replication
   H00093  Combined immunodeficiency
 Signal transduction
  nt06530  PI3K signaling
   H00093  Combined immunodeficiency
  nt06518  JAK-STAT signaling
   H00093  Combined immunodeficiency
  nt06516  TNF signaling
   H00093  Combined immunodeficiency
  nt06528  Calcium signaling
   H00093  Combined immunodeficiency
 Immune system
  nt06537  TCR/BCR signaling
   H00093  Combined immunodeficiency
Pathway
hsa04020 Calcium signaling pathway   
hsa04151 PI3K-Akt signaling pathway   
hsa04660 T cell receptor signaling pathway   
Network
nt06509 DNA replication
nt06516 TNF signaling
nt06518 JAK-STAT signaling
nt06528 Calcium signaling
nt06530 PI3K signaling
nt06537 TCR/BCR signaling
Gene
(CIDX/IMD6) IL2RG [HSA:3561] [KO:K05070]
(IMD9) ORAI1 [HSA:84876] [KO:K16056]
(IMD10) STIM1 [HSA:6786] [KO:K16059]
(IMD11) CARD11 [HSA:84433] [KO:K07367]
(IMD12) MALT1 [HSA:10892] [KO:K07369]
(IMD15) IKBKB [HSA:3551] [KO:K07209]
(IMD16) TNFRSF4 [HSA:7293] [KO:K05142]
(IMD17) CD3G [HSA:917] [KO:K06452]
(IMD21) GATA2 [HSA:2624] [KO:K17894]
(IMD22) LCK [HSA:3932] [KO:K05856]
(IMD24) CTPS1 [HSA:1503] [KO:K01937]
(IMD37) BCL10 [HSA:8915] [KO:K07368]
(IMD40) DOCK2 [HSA:1794] [KO:K12367]
(IMD48) ZAP70 [HSA:7535] [KO:K07360]
(IMD50) MSN [HSA:4478] [KO:K05763]
(IMD55) GINS1 [HSA:9837] [KO:K10732]
(IMD59) HYOU1 [HSA:10525] [KO:K09486]
(IMD71) ARPC1B [HSA:10095] [KO:K05757]
(IMD85) TOM1 [HSA:10043] [KO:K26401]
(IMD97) PIK3CG [HSA:5294] [KO:K21289]
(IMD110) STK4 [HSA:6789] [KO:K04411]
(IMD112) MAP3K14 [HSA:9020] [KO:K04466]
(IMD116) CD8A [HSA:925] [KO:K06458]
(IMD119) ICOSLG [HSA:23308] [KO:K06710]
(IMD120) POLD1 [HSA:5424] [KO:K02327]
(IMD128) COPG1 [HSA:22820] [KO:K17267]
(IMD131) IRF4 [HSA:3662] [KO:K09445]
(CCHDG) RAG1 [HSA:5896] [KO:K10628]
(CCHDG) RAG2 [HSA:5897] [KO:K10988]
Other DBs
ICD-11: 4A01.1
MeSH: D053632
OMIM: 312863 612782 612783 615206 617638 615468 618204 615592 615593 615607 614172 615758 615897 616098 616433 269840 300988 617827 233600 617718 619510 619802 614868 620449 608957 620825 620836 620983 621097 233650
Reference
  Authors
Kumar A, Teuber SS, Gershwin ME.
  Title
Current perspectives on primary immunodeficiency diseases.
  Journal
Clin Dev Immunol 13:223-59 (2006)
DOI:10.1080/17402520600800705
Reference
PMID:9737224
  Authors
Ten RM.
  Title
Primary immunodeficiencies.
  Journal
Mayo Clin Proc 73:865-72 (1998)
DOI:10.4065/73.9.865
Reference
  Authors
Lim MS, Elenitoba-Johnson KS.
  Title
The molecular pathology of primary immunodeficiencies.
  Journal
J Mol Diagn 6:59-83 (2004)
DOI:10.1016/S1525-1578(10)60493-X
Reference
  Authors
Morra M, Geigenmuller U, Curran J, Rainville IR, Brennan T, Curtis J, Reichert V, Hovhannisyan H, Majzoub J, Miller DT.
  Title
Genetic diagnosis of primary immune deficiencies.
  Journal
Immunol Allergy Clin North Am 28:387-412, x (2008)
DOI:10.1016/j.iac.2008.01.004
Reference
  Authors
Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.
  Title
Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
  Journal
J Allergy Clin Immunol 120:776-94 (2007)
DOI:10.1016/j.jaci.2007.08.053
Reference
PMID:20004777 (CD40LG, CD40, CD3G, CD8A, ZAP70)
  Authors
Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, Etzioni A, Hammartrom L, Nonoyama S, Ochs HD, Puck J, Roifman C, Seger R, Wedgwood J
  Title
Primary immunodeficiencies: 2009 update.
  Journal
J Allergy Clin Immunol 124:1161-78 (2009)
DOI:10.1016/j.jaci.2009.10.013
Reference
PMID:7883965 (IMD6)
  Authors
Schmalstieg FC, Leonard WJ, Noguchi M, Berg M, Rudloff HE, Denney RM, Dave SK, Brooks EG, Goldman AS
  Title
Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency.
  Journal
J Clin Invest 95:1169-73 (1995)
DOI:10.1172/JCI117765
Reference
PMID:20189884 (IMD9 IMD10)
  Authors
Feske S, Picard C, Fischer A
  Title
Immunodeficiency due to mutations in ORAI1 and STIM1.
  Journal
Clin Immunol 135:169-82 (2010)
DOI:10.1016/j.clim.2010.01.011
Reference
PMID:23374270 (IMD11)
  Authors
Stepensky P, Keller B, Buchta M, Kienzler AK, Elpeleg O, Somech R, Cohen S, Shachar I, Miosge LA, Schlesier M, Fuchs I, Enders A, Eibel H, Grimbacher B, Warnatz K
  Title
Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects.
  Journal
J Allergy Clin Immunol 131:477-85.e1 (2013)
DOI:10.1016/j.jaci.2012.11.050
Reference
PMID:23727036 (IMD12)
  Authors
Jabara HH, Ohsumi T, Chou J, Massaad MJ, Benson H, Megarbane A, Chouery E, Mikhael R, Gorka O, Gewies A, Portales P, Nakayama T, Hosokawa H, Revy P, Herrod H, Le Deist F, Lefranc G, Ruland J, Geha RS
  Title
A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency.
  Journal
J Allergy Clin Immunol 132:151-8 (2013)
DOI:10.1016/j.jaci.2013.04.047
Reference
PMID:30337470 (IMD15)
  Authors
Cardinez C, Miraghazadeh B, Tanita K, da Silva E, Hoshino A, Okada S, Chand R, Asano T, Tsumura M, Yoshida K, Ohnishi H, Kato Z, Yamazaki M, Okuno Y, Miyano S, Kojima S, Ogawa S, Andrews TD, Field MA, Burgio G, Morio T, Vinuesa CG, Kanegane H, Cook MC
  Title
Gain-of-function IKBKB mutation causes human combined immune deficiency.
  Journal
J Exp Med 215:2715-2724 (2018)
DOI:10.1084/jem.20180639
Reference
PMID:26215166 (IMD16)
  Authors
Webb GJ, Hirschfield GM, Lane PJ
  Title
OX40, OX40L and Autoimmunity: a Comprehensive Review.
  Journal
Clin Rev Allergy Immunol 50:312-32 (2016)
DOI:10.1007/s12016-015-8498-3
Reference
PMID:17277165 (IMD17)
  Authors
Recio MJ, Moreno-Pelayo MA, Kilic SS, Guardo AC, Sanal O, Allende LM, Perez-Flores V, Mencia A, Modamio-Hoybjor S, Seoane E, Regueiro JR
  Title
Differential biological role of CD3 chains revealed by human immunodeficiencies.
  Journal
J Immunol 178:2556-64 (2007)
DOI:10.4049/jimmunol.178.4.2556
Reference
PMID:21670465 (IMD21)
  Authors
Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY, Frucht DM, Vinh DC, Auth RD, Freeman AF, Olivier KN, Uzel G, Zerbe CS, Spalding C, Pittaluga S, Raffeld M, Kuhns DB, Ding L, Paulson ML, Marciano BE, Gea-Banacloche JC, Orange JS, Cuellar-Rodriguez J, Hickstein DD, Holland SM
  Title
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.
  Journal
Blood 118:2653-5 (2011)
DOI:10.1182/blood-2011-05-356352
Reference
PMID:22985903 (IMD22)
  Authors
Hauck F, Randriamampita C, Martin E, Gerart S, Lambert N, Lim A, Soulier J, Maciorowski Z, Touzot F, Moshous D, Quartier P, Heritier S, Blanche S, Rieux-Laucat F, Brousse N, Callebaut I, Veillette A, Hivroz C, Fischer A, Latour S, Picard C
  Title
Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency.
  Journal
J Allergy Clin Immunol 130:1144-1152.e11 (2012)
DOI:10.1016/j.jaci.2012.07.029
Reference
PMID:24870241 (IMD24)
  Authors
Martin E, Palmic N, Sanquer S, Lenoir C, Hauck F, Mongellaz C, Fabrega S, Nitschke P, Esposti MD, Schwartzentruber J, Taylor N, Majewski J, Jabado N, Wynn RF, Picard C, Fischer A, Arkwright PD, Latour S
  Title
CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation.
  Journal
Nature 510:288-92 (2014)
DOI:10.1038/nature13386
Reference
PMID:25365219 (IMD37)
  Authors
Torres JM, Martinez-Barricarte R, Garcia-Gomez S, Mazariegos MS, Itan Y, Boisson B, Rholvarez R, Jimenez-Reinoso A, del Pino L, Rodriguez-Pena R, Ferreira A, Hernandez-Jimenez E, Toledano V, Cubillos-Zapata C, Diaz-Almiron M, Lopez-Collazo E, Unzueta-Roch JL, Sanchez-Ramon S, Regueiro JR, Lopez-Granados E, Casanova JL, Perez de Diego R
  Title
Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity.
  Journal
J Clin Invest 124:5239-48 (2014)
DOI:10.1172/JCI77493
Reference
PMID:26083206 (IMD40)
  Authors
Dobbs K, Dominguez Conde C, Zhang SY, Parolini S, Audry M, Chou J, Haapaniemi E, Keles S, Bilic I, Okada S, Massaad MJ, Rounioja S, Alwahadneh AM, Serwas NK, Capuder K, Ciftci E, Felgentreff K, Ohsumi TK, Pedergnana V, Boisson B, Haskologlu S, Ensari A, Schuster M, Moretta A, Itan Y, Patrizi O, Rozenberg F, Lebon P, Saarela J, Knip M, Petrovski S, Goldstein DB, Parrott RE, Savas B, Schambach A, Tabellini G, Bock C, Chatila TA, Comeau AM, Geha RS, Abel L, Buckley RH, Ikinciogullari A, Al-Herz W, Helminen M, Dogu F, Casanova JL, Boztug K, Notarangelo LD
  Title
Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.
  Journal
N Engl J Med 372:2409-22 (2015)
DOI:10.1056/NEJMoa1413462
Reference
PMID:8202712 (IMD48)
  Authors
Elder ME, Lin D, Clever J, Chan AC, Hope TJ, Weiss A, Parslow TG
  Title
Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase.
  Journal
Science 264:1596-9 (1994)
DOI:10.1126/science.8202712
Reference
PMID:27405666 (IMD50)
  Authors
Lagresle-Peyrou C, Luce S, Ouchani F, Soheili TS, Sadek H, Chouteau M, Durand A, Pic I, Majewski J, Brouzes C, Lambert N, Bohineust A, Verhoeyen E, Cosset FL, Magerus-Chatinet A, Rieux-Laucat F, Gandemer V, Monnier D, Heijmans C, van Gijn M, Dalm VA, Mahlaoui N, Stephan JL, Picard C, Durandy A, Kracker S, Hivroz C, Jabado N, de Saint Basile G, Fischer A, Cavazzana M, Andre-Schmutz I
  Title
X-linked primary immunodeficiency associated with hemizygous mutations in the moesin (MSN) gene.
  Journal
J Allergy Clin Immunol 138:1681-1689.e8 (2016)
DOI:10.1016/j.jaci.2016.04.032
Reference
PMID:28414293 (IMD55)
  Authors
Cottineau J, Kottemann MC, Lach FP, Kang YH, Vely F, Deenick EK, Lazarov T, Gineau L, Wang Y, Farina A, Chansel M, Lorenzo L, Piperoglou C, Ma CS, Nitschke P, Belkadi A, Itan Y, Boisson B, Jabot-Hanin F, Picard C, Bustamante J, Eidenschenk C, Boucherit S, Aladjidi N, Lacombe D, Barat P, Qasim W, Hurst JA, Pollard AJ, Uhlig HH, Fieschi C, Michon J, Bermudez VP, Abel L, de Villartay JP, Geissmann F, Tangye SG, Hurwitz J, Vivier E, Casanova JL, Smogorzewska A, Jouanguy E
  Title
Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency.
  Journal
J Clin Invest 127:1991-2006 (2017)
DOI:10.1172/JCI90727
Reference
PMID:27913302 (IMD59)
  Authors
Haapaniemi EM, Fogarty CL, Keskitalo S, Katayama S, Vihinen H, Ilander M, Mustjoki S, Krjutskov K, Lehto M, Hautala T, Eriksson O, Jokitalo E, Velagapudi V, Varjosalo M, Seppanen M, Kere J
  Title
Combined immunodeficiency and hypoglycemia associated with mutations in hypoxia upregulated 1.
  Journal
J Allergy Clin Immunol 139:1391-1393.e11 (2017)
DOI:10.1016/j.jaci.2016.09.050
Reference
PMID:30254128 (IMD71)
  Authors
Brigida I, Zoccolillo M, Cicalese MP, Pfajfer L, Barzaghi F, Scala S, Oleaga-Quintas C, Alvarez-Alvarez JA, Sereni L, Giannelli S, Sartirana C, Dionisio F, Pavesi L, Benavides-Nieto M, Basso-Ricci L, Capasso P, Mazzi B, Rosain J, Marcus N, Lee YN, Somech R, Degano M, Raiola G, Caorsi R, Picco P, Moncada Velez M, Khourieh J, Arias AA, Bousfiha A, Issekutz T, Issekutz A, Boisson B, Dobbs K, Villa A, Lombardo A, Neven B, Moshous D, Casanova JL, Franco JL, Notarangelo LD, Scielzo C, Volpi S, Dupre L, Bustamante J, Gattorno M, Aiuti A
  Title
T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency.
  Journal
Blood 132:2362-2374 (2018)
DOI:10.1182/blood-2018-07-863431
Reference
PMID:31263572 (IMD85)
  Authors
Keskitalo S, Haapaniemi EM, Glumoff V, Liu X, Lehtinen V, Fogarty C, Rajala H, Chiang SC, Mustjoki S, Kovanen P, Lohi J, Bryceson YT, Seppanen M, Kere J, Heiskanen K, Varjosalo M
  Title
Dominant TOM1 mutation associated with combined immunodeficiency and autoimmune disease.
  Journal
NPJ Genom Med 4:14 (2019)
DOI:10.1038/s41525-019-0088-5
Reference
PMID:33054089 (IMD97)
  Authors
Thian M, Hoeger B, Kamnev A, Poyer F, Kostel Bal S, Caldera M, Jimenez-Heredia R, Huemer J, Pickl WF, Gross M, Ehl S, Lucas CL, Menche J, Hutter C, Attarbaschi A, Dupre L, Boztug K
  Title
Germline biallelic PIK3CG mutations in a multifaceted immunodeficiency with immune dysregulation.
  Journal
Haematologica 105:e488 (2020)
DOI:10.3324/haematol.2019.231399
Reference
PMID:22174160 (IMD110)
  Authors
Nehme NT, Schmid JP, Debeurme F, Andre-Schmutz I, Lim A, Nitschke P, Rieux-Laucat F, Lutz P, Picard C, Mahlaoui N, Fischer A, de Saint Basile G
  Title
MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival.
  Journal
Blood 119:3458-68 (2012)
DOI:10.1182/blood-2011-09-378364
Reference
PMID:29230214 (IMD112)
  Authors
Schlechter N, Glanzmann B, Hoal EG, Schoeman M, Petersen BS, Franke A, Lau YL, Urban M, van Helden PD, Esser MM, Moller M, Kinnear C
  Title
Exome Sequencing Identifies a Novel MAP3K14 Mutation in Recessive Atypical Combined Immunodeficiency.
  Journal
Front Immunol 8:1624 (2017)
DOI:10.3389/fimmu.2017.01624
Reference
PMID:11435463 (IMD116)
  Authors
de la Calle-Martin O, Hernandez M, Ordi J, Casamitjana N, Arostegui JI, Caragol I, Ferrando M, Labrador M, Rodriguez-Sanchez JL, Espanol T
  Title
Familial CD8 deficiency due to a mutation in the CD8 alpha gene.
  Journal
J Clin Invest 108:117-23 (2001)
DOI:10.1172/JCI10993
Reference
PMID:30498080 (IMD119)
  Authors
Roussel L, Landekic M, Golizeh M, Gavino C, Zhong MC, Chen J, Faubert D, Blanchet-Cohen A, Dansereau L, Parent MA, Marin S, Luo J, Le C, Ford BR, Langelier M, King IL, Divangahi M, Foulkes WD, Veillette A, Vinh DC
  Title
Loss of human ICOSL results in combined immunodeficiency.
  Journal
J Exp Med 215:3151-3164 (2018)
DOI:10.1084/jem.20180668
Reference
PMID:31449058 (IMD120)
  Authors
Conde CD, Petronczki OY, Baris S, Willmann KL, Girardi E, Salzer E, Weitzer S, Ardy RC, Krolo A, Ijspeert H, Kiykim A, Karakoc-Aydiner E, Forster-Waldl E, Kager L, Pickl WF, Superti-Furga G, Martinez J, Loizou JI, Ozen A, van der Burg M, Boztug K
  Title
Polymerase delta deficiency causes syndromic immunodeficiency with replicative stress.
  Journal
J Clin Invest 129:4194-4206 (2019)
DOI:10.1172/JCI128903
Reference
PMID:33529166 (IMD128)
  Authors
Bainter W, Platt CD, Park SY, Stafstrom K, Wallace JG, Peters ZT, Massaad MJ, Becuwe M, Salinas SA, Jones J, Beaussant-Cohen S, Jaber F, Yang JS, Walther TC, Orange JS, Rao C, Rakoff-Nahoum S, Tsokos M, Naseem SUR, Al-Tamemi S, Chou J, Hsu VW, Geha RS
  Title
Combined immunodeficiency due to a mutation in the gamma1 subunit of the coat protein I complex.
  Journal
J Clin Invest 131:140494 (2021)
DOI:10.1172/JCI140494
Reference
PMID:29408330 (IMD131)
  Authors
Bravo Garcia-Morato M, Aracil Santos FJ, Briones AC, Blazquez Moreno A, Del Pozo Mate A, Dominguez-Soto A, Beato Merino MJ, Del Pino Molina L, Torres Canizales J, Marin AV, Vallespin Garcia E, Feito Rodriguez M, Plaza Lopez Sabando D, Jimenez-Reinoso A, Mozo Del Castillo Y, Sanz Santaeufemia FJ, de Lucas-Laguna R, Cardenas PP, Casamayor Polo L, Coronel Diaz M, Vales-Gomez M, Roldan Santiago E, Ferreira Cerdan A, Nevado Blanco J, Corbi AL, Reyburn HT, Regueiro JR, Lopez-Granados E, Rodriguez Pena R
  Title
New human combined immunodeficiency caused by interferon regulatory factor 4 (IRF4) deficiency inherited by uniparental isodisomy.
  Journal
J Allergy Clin Immunol 141:1924-1927.e18 (2018)
DOI:10.1016/j.jaci.2017.12.995
Reference
PMID:20489056 (CCHDG)
  Authors
De Ravin SS, Cowen EW, Zarember KA, Whiting-Theobald NL, Kuhns DB, Sandler NG, Douek DC, Pittaluga S, Poliani PL, Lee YN, Notarangelo LD, Wang L, Alt FW, Kang EM, Milner JD, Niemela JE, Fontana-Penn M, Sinal SH, Malech HL
  Title
Hypomorphic Rag mutations can cause destructive midline granulomatous disease.
  Journal
Blood 116:1263-71 (2010)
DOI:10.1182/blood-2010-02-267583
LinkDB

» Japanese version

KEGG   DRUG: Teneliximab
Entry
D06071                      Drug                                   
Name
Teneliximab (USAN/INN)
Efficacy
Immunosuppressant, Anti-CD40 antibody
  Type
Monoclonal antibody
Comment
Treatment of auto-immune diseases and prevention of organ transplant rejection
Target
TNFRSF5 (CD40) [HSA:958] [KO:K03160]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04514  Cell adhesion molecules
hsa04620  Toll-like receptor signaling pathway
hsa05330  Allograft rejection
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Tumor necrosis factor receptors
    TNFRSF5 (CD40)
     D06071  Teneliximab (USAN/INN)
Other DBs
CAS: 299423-37-3
PubChem: 47207729
LinkDB

» Japanese version   » Back

KEGG   DRUG: Dacetuzumab
Entry
D08896                      Drug                                   
Name
Dacetuzumab (USAN)
Formula
C6452H9964N1732O1998S42
Exact mass
145019.9592
Mol weight
145109.36
Sequence
  Type
Peptide
Efficacy
Antineoplastic, Anti-CD40 antibody
  Type
Monoclonal antibody
Comment
Treatment of CD40-positive cancers
Target
TNFRSF5 (CD40) [HSA:958] [KO:K03160]
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Tumor necrosis factor receptors
    TNFRSF5 (CD40)
     D08896  Dacetuzumab (USAN)
Other DBs
CAS: 880486-59-9
PubChem: 96025579
LinkDB

» Japanese version   » Back

KEGG   DRUG: Lucatumumab
Entry
D08942                      Drug                                   
Name
Lucatumumab (USAN)
Efficacy
Antineoplastic, Anti-CD40 antibody
  Type
Monoclonal antibody
Target
TNFRSF5 (CD40) [HSA:958] [KO:K03160]
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Tumor necrosis factor receptors
    TNFRSF5 (CD40)
     D08942  Lucatumumab (USAN)
Other DBs
CAS: 903512-50-5
PubChem: 96025625
LinkDB

» Japanese version   » Back

KEGG   DRUG: Bleselumab
Entry
D11357                      Drug                                   
Name
Bleselumab (USAN/INN)
Formula
C6412H9906O2018S38N1690
Exact mass
144085.3862
Mol weight
144173.91
Sequence
(Heavy chain)
QLQLQESGPG LLKPSETLSL TCTVSGGSIS SPGYYGGWIR QPPGKGLEWI GSIYKSGSTY
HNPSLKSRVT ISVDTSKNQF SLKLSSVTAA DTAVYYCTRP VVRYFGWFDP WGQGTLVTVS
SASTKGPSVF PLAPCSRSTS ESTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
SGLYSLSSVV TVPSSSLGTK TYTCNVDHKP SNTKVDKRVE SKYGPPCPPC PAPEFEGGPS
VFLFPPKPKD TLMISRTPEV TCVVVDVSQE DPEVQFNWYV DGVEVHNAKT KPREEQFNST
YRVVSVLTVL HQDQLNGKEY KCKVSNKGLP SSIEKTISKA KGQPREPQVY TLPPSQEEMT
KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSR LTVDKSRWQE
GNVFSCSVMH EALHNHYTQK SLSLSLGK
(Light chain)
AIQLTQSPSS LSASVGDRVT ITCRASQGIS SALAWYQQKP GKAPKLLIYD ASNLESGVPS
RFSGSGSGTD FTLTISSLQP EDFATYYCQQ FNSYPTFGQG TKVEIKRTVA APSVFIFPPS
DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
(Disulfide bridge: H22-H97, H135-L213, H148-H204, H227-H'227, H230-H'230, H262-H322, H368-H426, H'22-H'97, H'135-L'213, H'148-H'204, H'262-H'322, H'368-H'426, L23-L88, L133-L193, L'23-L'88, L'133-L'193)
  Type
Peptide
Efficacy
Immunosuppressant, Anti-CD40 antibody
  Type
Monoclonal antibody
Comment
Preventing organ transplant rejection
Target
TNFRSF5 (CD40) [HSA:958] [KO:K03160]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04514  Cell adhesion molecules
hsa04620  Toll-like receptor signaling pathway
hsa05330  Allograft rejection
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Tumor necrosis factor receptors
    TNFRSF5 (CD40)
     D11357  Bleselumab (USAN/INN)
Other DBs
CAS: 1453067-91-8
PubChem: 384585335
LinkDB

» Japanese version   » Back

KEGG   DRUG: Selicrelumab
Entry
D11491                      Drug                                   
Name
Selicrelumab (USAN/INN)
Formula
C6476H9962N1726O2022S58
Exact mass
146117.3562
Mol weight
146208.63
Sequence
(Heavy chain)
QVQLVQSGAE VKKPGASVKV SCKASGYTFT GYYMHWVRQA PGQGLEWMGW INPDSGGTNY
AQKFQGRVTM TRDTSISTAY MELNRLRSDD TAVYYCARDQ PLGYCTNGVC SYFDYWGQGT
LVTVSSASTK GPSVFPLAPC SRSTSESTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP
AVLQSSGLYS LSSVVTVPSS NFGTQTYTCN VDHKPSNTKV DKTVERKCCV ECPPCPAPPV
AGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVQF NWYVDGVEVH NAKTKPREEQ
FNSTRFVVSV LTVVHQDWLN GKEYKCKVSN KGLPAPIEKT ISKTKGQPRE PQVYTLPPSR
EEMTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PMLDSDGSFF LYSKLTVDKS
RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
(Light chain)
DIQMTQSPSS VSASVGDRVT ITCRASQGIY SWLAWYQQKP GKAPNLLIYT ASTLQSGVPS
RFSGSGSGTD FTLTISSLQP EDFATYYCQQ ANIFPLTFGG GTKVEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H96, H140-L214, H153-H209, H232-H'232, H235-H'235, H266-H326, H372-H430, H'22-H'96, H'140-L'214, H'153-H'209, H'266-H'326, H'372-H'430, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  Type
Peptide
Efficacy
Antineoplastic, Anti-CD40 antibody
  Type
Monoclonal antibody
Comment
Treatment of colorectal cancer
Target
TNFRSF5 (CD40) [HSA:958] [KO:K03160]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04514  Cell adhesion molecules
hsa04620  Toll-like receptor signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Tumor necrosis factor receptors
    TNFRSF5 (CD40)
     D11491  Selicrelumab (USAN/INN)
Other DBs
CAS: 1622140-49-1
PubChem: 384585467
LinkDB

» Japanese version   » Back

KEGG   DRUG: Ravagalimab
Entry
D11597                      Drug                                   
Name
Ravagalimab (USAN/INN)
Formula
C6482H10014N1734O2024S42
Exact mass
145874.2244
Mol weight
145964.08
Sequence
(Heavy chain)
EVQLVESGGG LVKPGGSLRL SCAASGFTFS DYGMNWVRQA PGKGLEWIAY ISSGRGNIYY
ADTVKGRFTI SRDNAKNSLY LQMNSLRAED TAVYYCARSW GYFDVWGQGT TVTVSSASTK
GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PEAAGGPSVF
LFPPKPKDQL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR
VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSREEMTKN
QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN
VFSCSVLHEA LHNHYTQKSL SLSPGK
(Light chain)
DIVMTQSPDS LAVSLGERAT INCKSSQSLL NRGNQKNYLT WFQQKPGQPP KLLIYWASTR
ESGVPDRFSG SGSGTDFTLT ISSLQAEDVA VYYCQNDYTY PLTFGQGTKL EIKRTVAAPS
VFIFPPSDEQ LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS
LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC
(Disulfide bridge: H22-H96, H143-H199, H219-L220, H225-H'225, H228-H'228, H260-H320, H366-H424, H'22-H'96, H'143-H'199, H'219-L'220, H'260-H'320, H'366-H'424, L23-L94, L140-L200, L'23-L'94, L'140-L'200)
  Type
Peptide
Efficacy
Anti-inflammatory, Anti-CD40 antibody
  Type
Monoclonal antibody
Comment
Treatment of inflammatory and autoimmune diseases
Target
TNFRSF5 (CD40) [HSA:958] [KO:K03160]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04514  Cell adhesion molecules
hsa04620  Toll-like receptor signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Tumor necrosis factor receptors
    TNFRSF5 (CD40)
     D11597  Ravagalimab (USAN/INN)
Other DBs
CAS: 2050816-56-1
PubChem: 405226464
LinkDB

» Japanese version   » Back

KEGG   DRUG: Iscalimab
Entry
D11610                      Drug                                   
Name
Iscalimab (USAN/INN)
Formula
C6470H10028N1744O2022S46
Exact mass
145980.2631
Mol weight
146070.40
Sequence
(Heavy chain)
QVQLVESGGG VVQPGRSLRL SCAASGFTFS SYGMHWVRQA PGKGLEWVAV ISYEESNRYH
ADSVKGRFTI SRDNSKITLY LQMNSLRTED TAVYYCARDG GIAAPGPDYW GQGTLVTVSS
ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKRVEP KSCDKTHTCP PCPAPELLGG
PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYA
STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSREE
MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
QQGNVFSCSV MHEALHNHYT QKSLSLSPGK
(Light chain)
DIVMTQSPLS LTVTPGEPAS ISCRSSQSLL YSNGYNYLDW YLQKPGQSPQ VLISLGSNRA
SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCMQARQTP FTFGPGTKVD IRRTVAAPSV
FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
(Disulfide bridge: H22-H96, H147-H203, H223-L219, H229-H'229, H232-H'232, H264-H324, H370-H428, H'22-H'96, H'147-H'203, H'223-L'219, H'264-H'324, H'370-H'428, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  Type
Peptide
Efficacy
Immunosuppressant, Anti-CD40 antibody
  Type
Monoclonal antibody
Comment
Renal transplant, Sjogren's syndrome
Target
TNFRSF5 (CD40) [HSA:958] [KO:K03160]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04514  Cell adhesion molecules
hsa04620  Toll-like receptor signaling pathway
hsa05330  Allograft rejection
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Tumor necrosis factor receptors
    TNFRSF5 (CD40)
     D11610  Iscalimab (USAN/INN)
Other DBs
CAS: 2031153-61-2
PubChem: 405226477
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system